Quantum Computing Leader IonQ Strengthens Board with New Director Stock Package

Rhea-AI Filing Summary

IonQ director Gabrielle B. Toledano received a grant of 5,513 restricted stock units (RSUs) on June 18, 2025. Following this transaction, Toledano's direct ownership increased to 6,305 shares.

Key terms of the RSU award:

• Grant was made at $0 exercise price
• RSUs will vest in full at the earlier of:
  • 2026 Annual Meeting (or day before if service ends at meeting)
  • June 18, 2026
• Vesting is contingent on continued service as Board member

This Form 4 filing represents standard equity compensation for non-employee directors, aligning the director's interests with shareholders through stock ownership.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

TOLEDANO GABRIELLE B

(Last) (First) (Middle)

C/O IONQ, INC.

4505 CAMPUS DRIVE

(Street)

COLLEGE PARK MD 20740

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
IonQ, Inc. [ IONQ ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/18/2025		A		5,513(1)	A	$0	6,305	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents a restricted stock unit ("RSU") award. The RSUs will vest in full on the earlier of (i) the date of the 2026 Annual Meeting (or the date immediately prior to the 2026 Annual Meeting if the Reporting Person's service as a director ends at such Annual Meeting), or (ii) June 18, 2026, subject in all cases to the Reporting Person's continued service as a member of the Board of Directors through such vesting date.

	/s/ Stacey Giamalis, Attorney-in-Fact	06/18/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

How many IONQ shares did Director Gabrielle Toledano receive on June 18, 2025?

According to the Form 4 filing, Director Gabrielle Toledano received 5,513 restricted stock units (RSUs) of IONQ on June 18, 2025.

What is the vesting schedule for IONQ Director Toledano's RSU grant?

The RSUs will vest in full on the earlier of: (1) the date of the 2026 Annual Meeting (or the day before if Toledano's service ends at that meeting), or (2) June 18, 2026, subject to continued service as a Board member through the vesting date.

How many IONQ shares does Gabrielle Toledano own after the June 18, 2025 transaction?

Following the RSU grant, Gabrielle Toledano beneficially owns 6,305 shares of IONQ common stock directly (indicated by 'D' in the ownership form column).

What was the purchase price of IONQ RSUs granted to Director Toledano?

The RSUs were granted at $0 cost to Director Toledano, as shown in the 'Price' column of Table I in the Form 4 filing.